The pituitary gland is a small, globular gland located underneath the brain that plays a major role in the hormonal system. It synthetizes and release reulatory peptides that communicate the need or the exaggeration of hormones for the thyroid gland, the adrenals and gonades, for instance. Due to this central role played in our biology, pituitary aging may contribute to the reduction of hormonal processes and hormone levels in our body – as is the case with menopause, for instance. This is why stem cell biologist Hugo Vankelecom and his colleagues from the Department of Development and Regeneration at KU Leuven, have discovered that the pituitary gland in mice ages as the result of an age-related form of chronic inflammation. It may be possible to slow down this process or even partially repair it. The researchers have published their findings in the journal PNAS USA. The study also provides significant insight into the stem cells in the ageing pituitary gland. In 2012, the same team showed that a prompt reaction of these stem cells to injury in the gland leads to repair of the tissue, even in adult animals.
Professor Vankelecom explained thorougghly: “My research group discovered that the pituitary gland ages as a result of a form of chronic inflammation that affects tissue and even the organism as a whole. This natural process usually goes unnoticed and is referred to as ‘inflammaging’ — a contraction of inflammation and ageing. Inflammaging has previously been linked to the ageing of other organs. As a result of this new study, we now know that stem cells in the pituitary do not lose this regenerative capacity when the organism ages. In fact, the stem cells are only unable to do their job because, over time, the pituitary becomes an ‘inflammatory environment’ as a result of the chronic inflammation. But as soon as the stem cells are taken out of this environment, they show the same properties as stem cells from a young pituitary. This insight opens up a number of potential therapeutic avenues: would it be possible to reactivate the pituitary? This wouldn’t just involve slowing down hormonal ageing processes, but also repairing the damage caused by a tumour in the pituitary, for example”.
“No fewer than one in every 1,000 people is faced with this kind of tumour — which causes damage to the surrounding tissue — at some point. The quality of life of many of these patients would be drastically improved if we could repair this damage. We may be able to do so by activating the stem cells already present — for which our present study also provides new indications — or even by transplanting cells. That said, these new treatment options are not quite around the corner just yet, as the step from fundamental research to an actual therapy can take years to complete. For the time being, our study sets out a potential direction for further research. But our data also suggests another interesting avenue: the use of anti-inflammatory drugs to slow down pituitary ageing or rejuvenate an ageing pituitary. Indeed, several studies have shown that anti-inflammatory drugs may have a positive impact on some ageing organs. No research has yet been performed on this effect in relation to the pituitary”.
Dr Vankelecom and his colleagues studied the pituitary of mice, so further research is required to demonstrate whether their findings also apply to humans, because, it is known that mice have a much greater regeneration capacity than humans. They can repair damaged teeth, for instance, while humans have lost this ability over the course of their evolution. Regardless, there are plenty of signs suggesting that pituitary processes in mice and humans are similar, and we have recent evidence to hand that gene expression in the pituitaries of humans and mice is very similar. As such, it is highly likely that the insights we gained will equally apply to humans. In this study the researchers demonstrated that resident stem cells in pituitary are functional and they may become activated by a cytokine called interleukin-6 (IL-6). Somehow this seems odd, since cytokines like IL-6, IL-1 and TNF-alpha are up-regulated in aging and drive the continuous inflammatory background that is responsible for the cellular aging, a concept evolved as “inflammaging”.
It is likely that the microenvironment adn other unknown regulatory patterns are implicated in this biological phenomenon. After all, inflammaging it’s just “ten years old”.
- Edited by Dr. Gianfrancesco Cormaci, PhD, specialist in Clinical Biochemistry.
Vennekens A et al. PNAS USA 2021 Jun; 118(25):e2100052118.
Laporte E et al. Front Endocrinol (Lausanne) 2021; 11:604519.
Vennekens A, Vankelecom H. Pituitary 2019 Jun; 22(3):212-219.
Dott. Gianfrancesco Cormaci
Ultimi post di Dott. Gianfrancesco Cormaci (vedi tutti)
- Indagini sul diabete tipo 2: oltre al tipo 1, anche genetica e virus intervengono in questa forma? - Maggio 16, 2022
- Toxoplasmosi e le sue forme: il pericolo odierno che rappresenta e gli sforzi in campo per combatterla - Maggio 16, 2022
- Melasma management: tranexamic acid to overtake expectances through the treatments’ list - Maggio 15, 2022
- Cronicizzazione di asma, BPCO e altre condizioni polmonari: ecco svelato il colpevole rimasto nell’ombra - Maggio 13, 2022
- Antidolorifici per trattare il dolore: è davvero il modo giusto? Le vecchie tesi sfidate dalle nuove scoperte - Maggio 13, 2022